|
CUL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.244980E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.594090E-02 |
| Normal-vs-Stage2 |
2.615800E-01 |
| Normal-vs-Stage3 |
4.527800E-01 |
| Normal-vs-Stage4 |
7.318600E-01 |
| Stage1-vs-Stage2 |
7.243800E-01 |
| Stage1-vs-Stage3 |
2.205800E-02 |
| Stage1-vs-Stage4 |
1.843040E-01 |
| Stage2-vs-Stage3 |
1.598030E-01 |
| Stage2-vs-Stage4 |
3.112600E-01 |
| Stage3-vs-Stage4 |
8.621400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.820500E-02 |
| Normal-vs-AfricanAmerican |
2.200800E-01 |
| Normal-vs-Asian |
3.638800E-01 |
| Caucasian-vs-AfricanAmerican |
7.724800E-01 |
| Caucasian-vs-Asian |
6.428500E-02 |
| AfricanAmerican-vs-Asian |
1.141040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.815400E-03 |
| Normal-vs-Female |
1.977220E-01 |
| Male-vs-Female |
8.645900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.962100E-02 |
| Normal-vs-Extreme_Weight |
1.964360E-03 |
| Normal-vs-Obese |
8.500200E-01 |
| Normal-vs-Extreme_Obese |
3.252200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.389200E-01 |
| Normal_Weight-vs-Obese |
1.062210E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.786400E-01 |
| Extreme_Weight-vs-Obese |
1.412190E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.698200E-01 |
| Obese-vs-Extreme_Obese |
3.314200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.412600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.458400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.482700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.032050E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.760100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.882000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.456800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.660300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.269970E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.198600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.174400E-02 |
| Normal-VS-Type2 PRCC |
1.359370E-01 |
| Normal-VS-KIRP CIMP |
1.936490E-02 |
| Normal-VS-Unclassified PRCC |
8.802800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.349600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.616210E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.664650E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.218000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.485400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.635600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.562100E-02 |
| Normal-vs-N1 |
1.222600E-01 |
| Normal-vs-N2 |
6.627800E-01 |
| N0-vs-N1 |
7.024400E-03 |
| N0-vs-N2 |
9.156000E-01 |
| N1-vs-N2 |
2.716000E-01 |
|
|
